Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,552
Closed -$349K 5802
2025
Q2
$349K Sell
3,552
-27,784
-89% -$2.63M ﹤0.01% 4669
2025
Q1
$2.9M Buy
31,336
+605
+2% +$55.8K ﹤0.01% 2601
2024
Q4
$2.79M Sell
30,731
-1,794
-6% -$165K ﹤0.01% 2552
2024
Q3
$3.14M Buy
32,525
+2,157
+7% +$210K ﹤0.01% 2335
2024
Q2
$2.79M Buy
30,368
+18,817
+163% +$1.75M ﹤0.01% 2325
2024
Q1
$1.06M Sell
11,551
-8,707
-43% -$816K ﹤0.01% 3124
2023
Q4
$1.93M Buy
20,258
+75
+0.4% +$7K ﹤0.01% 2437
2023
Q3
$1.89M Buy
20,183
+12,292
+156% +$1.14M ﹤0.01% 2341
2023
Q2
$722K Sell
7,891
-225
-3% -$18.5K ﹤0.01% 3136
2023
Q1
$597K Sell
8,116
-406
-5% -$35.1K ﹤0.01% 3175
2022
Q4
$712K Buy
8,522
+4,573
+116% +$412K ﹤0.01% 2931
2022
Q3
$382K Buy
3,949
+155
+4% +$18.5K ﹤0.01% 3384
2022
Q2
$399K Buy
3,794
+503
+15% +$64.3K ﹤0.01% 3389
2022
Q1
$567K Buy
3,291
+22
+0.7% +$3.29K ﹤0.01% 3092
2021
Q4
$529K Sell
3,269
-36
-1% -$5.79K ﹤0.01% 3231
2021
Q3
$493K Sell
3,305
-314
-9% -$65.3K ﹤0.01% 3223
2021
Q2
$886K Sell
3,619
-472
-12% -$124K ﹤0.01% 2667
2021
Q1
$1.08M Buy
4,091
+323
+9% +$91.1K ﹤0.01% 2330
2020
Q4
$1.1M Sell
3,768
-91
-2% -$23.3K ﹤0.01% 2103
2020
Q3
$912K Buy
3,859
+258
+7% +$58.7K ﹤0.01% 2017
2020
Q2
$715K Sell
3,601
-122
-3% -$22.8K ﹤0.01% 2100
2020
Q1
$683K Sell
3,723
-5,904
-61% -$1.05M ﹤0.01% 1881
2019
Q4
$1.61M Buy
9,627
+6,658
+224% +$990K ﹤0.01% 1510
2019
Q3
$389K Sell
2,969
-511
-15% -$66.5K ﹤0.01% 2468
2019
Q2
$423K Sell
3,480
-393
-10% -$46.6K ﹤0.01% 2400
2019
Q1
$477K Buy
3,873
+1,308
+51% +$164K ﹤0.01% 2262
2018
Q4
$300K Buy
+2,565
New +$302K ﹤0.01% 2464

Other funds holding AMED

LPL Financial's AMED Position: Q3 2025 in Review

LPL Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,552 shares — an estimated $349K sold.

LPL Financial first reported a position in AMED in Q4 2018 and held it in 27 quarters. The position peaked at $3.14M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • LPL Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 3,552 Amedisys shares in Q3 2025, an estimated $349K.
  • LPL Financial first reported a position in Amedisys in Q4 2018 and held it in 27 quarters.
  • LPL Financial's Amedisys position peaked at $3.14M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.